- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Epithelial Ovarian Cancer in Belgium
Total 476 results
-
Universitaire Ziekenhuizen KU LeuvenAstraZenecaActive, not recruitingOvarian Epithelial CancerBelgium
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Belgium, Czechia, Germany
-
Hoffmann-La RocheCompletedColorectal Cancer, Ovarian CancerBelgium, Spain, United Kingdom
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
Medical University InnsbruckEuropean CommissionTerminatedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerFrance, Austria, Belgium, Germany
-
Medical University of ViennaCompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Belgium, Czechia, Denmark, Germany, Ireland, Netherlands, United Kingdom
-
Janssen Research & Development, LLCCompletedNeoplasms | Neoplasms, Breast | Neoplasms, Ovarian | Advanced or Refractory Solid MalignanciesUnited States, United Kingdom, Spain, Belgium
-
University Hospital, GhentCentre Hospitalier Universitaire Vaudois; University Ghent; Hopital Lariboisière and other collaboratorsCompletedBreast Cancer Stage IV | Peritoneal Carcinomatosis | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Breast Cancer Stage IIIB | Breast Cancer Stage IIIc | Ovarian Cancer Stage IIIB | Stomach Cancer Stage III | Stomach Cancer Stage IV With Metastases | Pancreas Cancer, Stage III | Pancreas Cancer, Stage...Belgium
-
IpsenCompletedMetastatic Renal Cell Cancer | Advanced or Metastatic Hepatocellular Cancer | Advanced or Metastatic Ovarian Cancer | Advanced or Metastatic Gastric CarcinomaBelgium, Canada, France, Spain, United Kingdom
-
Jules Bordet InstituteCompletedOvarian Cancer | Peritoneal CarcinomatosisBelgium
-
Clavis PharmaCompletedOvarian CancerBelgium, Italy
-
Cristal TherapeuticsCompletedCancer | Ovarian CancerNetherlands, Belgium, United Kingdom
-
Universitaire Ziekenhuizen KU LeuvenCompletedOvarian Cancer | Peritoneal MetastasisBelgium
-
Universitaire Ziekenhuizen KU LeuvenTerminated
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
AmgenCompletedCarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerBelgium, Spain, Australia
-
EBMT Solid Tumors Working PartyCompletedOvarian CancerSwitzerland, Spain, United Kingdom, Italy, Slovakia, Germany, Belgium, Austria, Czech Republic
-
UNICANCERActive, not recruitingOvarian Epithelial Cancer RecurrentFrance, Belgium, Spain
-
University Hospital, GhentCompletedOvarian Cancer | Primary Peritoneal CancerBelgium
-
Janssen Research & Development, LLCCompletedNeoplasmsUnited States, Spain, Canada, Belgium
-
iTeos Belgium SACompleted
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT); Myriad... and other collaboratorsActive, not recruitingAdvanced Ovarian CancerCanada, Denmark, Germany, Italy, Spain, United States, Belgium, Poland, France, Korea, Republic of, Brazil, Hungary, Japan, Peru, Turkey, China, Austria, Bulgaria, Finland, Romania
-
OnxeoCompletedAdvanced CancerFrance, Belgium
-
Aprea TherapeuticsCompletedHigh-grade Serous Ovarian CancerSpain, United Kingdom, Belgium
-
Eli Lilly and CompanyCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Germany, Belgium
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
ImmunoGen, Inc.CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Belgium, Canada
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Jules Bordet InstituteCompletedOvarian Carcinoma | RelapseBelgium
-
Ganymed Pharmaceuticals GmbHCompletedOvarian CancerBelgium, Germany
-
Jules Bordet InstituteCompletedFallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaBelgium
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fonds Gaston Ithier; Association Jules BordetRecruiting
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedOvarian CancerBelgium, United States, United Kingdom
-
AGO Study GroupArbeitsgemeinschaft Gynaekologische Onkologie Austria; MITOCompletedOvarian CancerGermany, Belgium, Italy, Austria
-
Hoffmann-La RocheCompleted
-
Nordic Society of Gynaecological Oncology - Clinical...European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerItaly, Canada, Israel, Norway, Belgium, Netherlands, Denmark, Portugal, Spain, United States
-
Clavis PharmaCompletedAdvanced Adenocarcinoma of PancreasNorway, Belgium
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
Medical Research CouncilEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerSpain, Belgium, France, Netherlands, Austria, United Kingdom, Italy, South Africa, Portugal, Ireland
-
Oasmia Pharmaceutical ABCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUkraine, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Hungary, Latvia, Lithuania, Romania, Russian Federation, Serbia, Slovakia, Sweden
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)CompletedEpithelial Ovarian CancerDenmark, France, Germany, Italy, Spain, Poland, Belgium, Canada, United Kingdom, Israel, Norway
-
AZ-VUBAstraZeneca; Kom Op Tegen KankerRecruitingAdvanced Cancers Harbouring Mutations in HRGBelgium
-
Universitair Ziekenhuis BrusselRecruiting
-
Universitaire Ziekenhuizen KU LeuvenUZ Leuven, Leuven, Belgium; Policlinico Universitario A. Gemelli, IRCSS, Rome... and other collaboratorsRecruitingCervical Cancer | Ovarian Neoplasms | Ovarian Cancer | Metastatic Cancer | Pelvic Cancer | Endometrial Cancer | Ovarian Carcinoma | Uterus Cancer | Sarcoma UterusBelgium, Czechia, Italy, Sweden
-
Salubris Biotherapeutics IncRecruitingMelanoma | Clear Cell Renal Cell Carcinoma | Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Advanced Solid Tumor | Epithelial Ovarian Cancer | Non-small Cell... and other conditionsBelgium, Spain
-
NovoCure Ltd.UnknownOvarian CarcinomaSwitzerland, Belgium, Germany, Spain
-
National Cancer Institute, NaplesActive, not recruiting
-
Mateon TherapeuticsTerminatedPlatinum Resistant Ovarian CancerUnited States, Belgium, Germany